Breaking News

Trending right now:
May 03, 2013

UK Offers £30 Million to Oxford Health Research Centre to Tackle Major Diseases

image The UK’s world-leading medical science base has been boosted by £30 million of government and private investment in a new cutting edge research centre at the University of Oxford, Prime Minister David Cameron announced today.

The Big Data Institute will capture and analyse extensive sets of health data for the detection, monitoring, treatment and prevention of a broad range of conditions from cancer, diabetes, stroke and high blood pressure through to pathogens and infectious diseases, such as malaria and influenza. The project has received £10 million under the second round of the UK Research Partnership Investment Fund (UK RPIF), matched by a further £20 million donation from the Li Ka Shing Foundation.

The investment marks the second phase of the £90 million Li Ka Shing Centre for Health Information and Discovery, launched by the Prime Minister David Cameron and Sir Ka-shing Li today and set to be a world leader in high tech, computer-driven medical research. The first phase, the Target Discovery Institute, received £10 million from the first round of UK RPIF. This will use high throughput biology to define better drug targets in collaboration with industry.

The Prime Minister said “I am delighted to be backing our medical science sector and supporting the Li Ka Shing Centre for Health Information and Discovery, which has the potential to revolutionise medical research and healthcare in this country and beyond. The Li Ka Shing Centre for Health Information and Discovery will pioneer new advances in the analysis of medical data which can help scientists to better understand human disease and its treatment.”

Minister for Universities and Science David Willetts said, “This cutting edge centre reinforces the UK’s position as a world leader in medical research and life sciences. Through harnessing the unique health data we have in the UK we can discover new insights into diseases and develop groundbreaking personalised drugs and technologies, driving growth and bringing benefits to patients. This project yet again shows that charities and businesses want to collaborate with our excellent universities to tackle global challenges like public health. It builds on the £100 million announced by the Prime Minister for DNA mapping for patients with cancer and rare diseases, and will keep the UK ahead in the global race for better treatments and care.”